SPOTLIGHT -
Guidelines for Pediatric Migraine Clinical Trial Design Released, FDA Grants AMT-130 Fast Track Designation for Huntington Disease, ZX008 Receives RFL for Dravet Syndrome
Neurology News Network for the week of April 13, 2019.
Clardibine Approved for Relapsing, Secondary Progressive MS, Cervella Cranial Electrotherapy Approved for Insomnia, and Management of Stroke With Tandem Occlusion
Neurology News Network for the week of April 6, 2019.
Siponimod Approved for SPMS, AVP-786 Phase 3 Results for Treatment of Agitation in Alzheimer-Related Dementia, and Mobile Technology for Care of Parkinson Disease
Neurology News Network for the week of March 30, 2019.
Quality of Life is Predictive of DBS Outcomes in Early Parkinson, Lack of Approved Therapies for MS Symptoms, and Ubrogepant for Acute Treatment of Migraine in Adults
Neurology News Network for the week of March 22, 2019.
Ned Sharpless as Acting FDA Commissioner, Temelimab in MS Extension Trial, and Post-Stroke Blood Panel Predicting Dementia
Neurology News Network for the week of March 16, 2019.
Gottlieb Resignation, Priority Review Granted to Galcanezumab for Prevention of Episodic Cluster Headache, Neurologists Treating MS Deviate From DMT Use
Neurology News Network for the week of March 9, 2019.
NDA Accepted for SRP-4053 for DMD, MPRI 2.0 Differentiates Parkinson and Progressive Supranuclear Palsy, and Young Donor Plasma Infusion Warning
Neurology News Network for the week of February 23, 2019.
Patients with Parkinson at Greater Risk for Dementia After DBS Implant, a Novel ALS Diagnostic Index, Preliminary IGNITE-DMD Trial Findings
Neurology News Network for the week of February 14, 2019.
SPRINT-MIND Trial Results, Alemtuzumab and Rituximab Safe for MS, CAP-1002 for Duchenne Muscular Dystrophy
Neurology News Network for the week of February 2, 2019.
Ocrelizumab Compared to Other DMTs, Effects of Lemborexant on Next-Day Driving, BHV-3241 Gets FDA OK for Clinical Trial
Neurology News Network for the week of January 26, 2019.
AHS Statement on CGRP Inhibitors, NDA Submitted for Lemborexant, Dabigatran Assessed in Alzheimer
Neurology News Network for the week of January 19, 2019.
Fumarate Bioequivalent for MS, Embrace Smartband Approval, Alzheimer Biomarkers Identified, Long-Term Perampanel Data
Neurology News Network for the week of January 12, 2019.
Solriamfetol PDUFA Date Pushed, Recognizing Parkinson Disease, Chronic Migraine Peer Exchange Program
Neurology News Network for the week of January 5, 2019.
Oxtellar XR Approved as Monotherapy, Pregnancy Safety Data for Betaseron, and Biologic Brain Changes in Migraine
Neurology News Network for the week of December 22, 2018.
Zilucoplan for Mysathenia Gravis, AXS-05 for Agitation in Alzheimer, and Chronic Migraine Management
Neurology News Network for the week of December 15, 2018.
Fingolimod Issued a Safety Warning, an NDA for BHV-0223 for ALS, and Lifestyle Modifications for Patients with Migraine
Neurology News Network for the week of December 1, 2018.
Galcanezumab for Cluster Headache, a Link Between Carotid Webs and Stroke, Managing Migraine Patient Relationships
Neurology News Network for the week of November 24, 2018.
An FDA Warning Letter, the Amyloid Hypothesis and Alzheimer Disease, Adverse Events with Triptan Use
Neurology News Network for the week of November 17, 2018.
Confounding Outcomes in Alzheimer, AFib and Dementia Risk, Cognitive Issues in Epilepsy, and MRI Imaging
Neurology News Network for the week of November 10, 2018.
Sodium Oxybate Approved, ANAVEX 2-73 Shows Positive Results, Ubrogepant for Acute Migraine Care, and Stroke Risk with Migraine
Neurology News Network for the week of November 3, 2018.
Novel Deep Brain Stimulation System, ITI-214 Safe for Parkinson Disease, Elizabeth Ross on the Field's Progress
Neurology News Network for the week of Oct. 27, 2018.
New Alzheimer Association AUC, Patisiran Findings from AANEM, Evobrutinib findings from ECTRIMS
Neurology News Network for the week of October 20, 2018.
Siponimod NDA Accepted, New Appropriate Use Criteria for Alzheimer Disease Diagnosis, Disease-Modifying Therapy
Neurology News Network for the week of Oct. 12, 2018.
Never Events Common in Parkinson, Donepezil Fails to Prevent Psychosis, Helping Patients Live Well
Neurology News Network for the week of October 6, 2018.
Galcanezumab Approved, Pimavanserin Safety Confirmed, Treating Augmentation in RLS, Genetics in Alzheimer
Neurology News Network for the week of September 28, 2018.
FDA Approves Fremanezumab, Behavioral Activation Therapy for MCI, Choosing DMTs for MS
Neurology News Network for the week of September 22, 2018.
XEN496 for KCNQ2 Epileptic Encephalopathy, the State of Acute Stroke Care, and Ocrelizumab's Success
Neurology News Network for the week of September 15, 2018.
